Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of [...]
Sybil Shainwald, Lawyer Who Fought for Women’s Health, Dies at 96
After taking part in a landmark case against the manufacturers [...]
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its [...]
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for [...]
Trump’s Tariff Threat for Drug imports Poses Big Political Risks
Levies on Americans’ daily prescriptions and other medicines could raise [...]
Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the [...]
Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Loss
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s [...]
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role [...]
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain [...]
Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cut
Eli Lilly will now sell cheaper vials of Zepbound, presenting [...]